文献速递类风湿关节炎

关节炎临床前模型:免疫治疗与免疫耐受研究的关键工具

Preclinical models of arthritis for studying immunotherapy and immune tolerance.
PubMed 文献 · Ann Rheum Dis · 2021-08-11

本文综述了关节炎临床前动物模型在免疫治疗和免疫耐受研究中的应用,指出越来越早识别类风湿关节炎(RA)高风险个体使预防或治愈疾病更具可行性。抗原特异性免疫治疗通过重建免疫自耐受具有诱导疾病缓解的潜力,优于需长期对症治疗的现有方法。综述强调应聚焦疾病初始诱导阶段的免疫过程而非终末期病理后果,并评述现有模型及研究空白。

要点

  • 早期识别RA高风险个体(如自身抗体阳性伴轻微症状)使预防或治愈疾病成为可能
  • 抗原特异性免疫治疗旨在重建免疫自耐受,有望诱导疾病缓解而非仅长期对症治疗
  • 临床前模型应聚焦自耐受突破及无症状自身免疫向关节痛和骨丢失进展的关键过程

核心结论

  • 聚焦参与疾病初始诱导的免疫过程而非终末期病理后果,对开发和评估早期干预的新型免疫治疗至关重要。

研究设计与样本

  • 本文为综述,描述并评述关节炎及更广泛自身免疫领域可能满足上述标准的现有动物模型。

主要发现

  • 现有动物模型用于理解疾病机制和评估新型免疫治疗方法。
  • 研究疾病发展关键过程(如自耐受突破触发自身免疫、无症状自身免疫向关节痛和骨丢失进展)需要相应模型。
  • 这些模型也有助于评估前RA期的治疗反应。

临床怎么用

  • 临床前模型可用于评估前RA期治疗反应,支持早期干预策略的开发与评价。

局限性

  • 综述识别了在动物模型中研究上述关键过程的能力存在重要空白,需进一步研究靶向这些空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Increasingly earlier identification of individuals at high risk of rheumatoid arthritis (RA) (eg, with autoantibodies and mild symptoms) improves the feasibility of preventing or curing disease. The use of antigen-specific immunotherapies to reinstate immunological self-tolerance represent a highly attractive strategy due to their potential to induce disease resolution, in contrast to existing approaches that require long-term treatment of underlying symptoms.Preclinical animal models have been used to understand disease mechanisms and to evaluate novel immunotherapeutic approaches. However, models are required to understand critical processes supporting disease development such as the breach of self-tolerance that triggers autoimmunity and the progression from asymptomatic autoimmunity to joint pain and bone loss. These models would also be useful in evaluating the response to treatment in the pre-RA period.This review proposes that focusing on immune processes contributing to initial disease induction rather than end-stage pathological consequences is essential to allow development and evaluation of novel immunotherapies for early intervention. We will describe and critique existing models in arthritis and the broader field of autoimmunity that may fulfil these criteria. We will also identify key gaps in our ability to study these processes in animal models, to highlight where further research should be targeted.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Meehan GR, Thomas R, Al Khabouri S, et al. Preclinical models of arthritis for studying immunotherapy and immune tolerance. Ann Rheum Dis. 2021. PMID: 34380700. doi:10.1136/annrheumdis-2021-220043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。